BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Obi ON. Health-Related Quality of Life in Sarcoidosis. Semin Respir Crit Care Med 2020;41:716-32. [PMID: 32583381 DOI: 10.1055/s-0040-1710080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Saketkoo LA, Obi ON, Patterson KC, Russell AM. Ageing with Interstitial lung disease: preserving health and well being. Curr Opin Pulm Med 2022;28:321-36. [PMID: 35749798 DOI: 10.1097/MCP.0000000000000880] [Reference Citation Analysis]
2 Obi ON, Lower EE, Baughman RP. Biologic and advanced immunomodulating therapeutic options for sarcoidosis: a clinical update. Expert Rev Clin Pharmacol 2021;14:179-210. [PMID: 33487042 DOI: 10.1080/17512433.2021.1878024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Baughman RP, Kotzin J, Lower EE. The Value of a Patient Global Assessment in Management of Sarcoidosis. Lung 2021;199:357-62. [PMID: 34255140 DOI: 10.1007/s00408-021-00455-5] [Reference Citation Analysis]
4 Obi ON, Judson MA, Birring SS, Maier LA, Wells AU, Lower EE, Baughman RP. Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI). Respir Med 2021;:106436. [PMID: 33992496 DOI: 10.1016/j.rmed.2021.106436] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]